Economic and Quality-of-Life Impact of NSAIDs in Rheumatoid Arthritis: A Conceptual Framework and Selected Literature Review

Medicine & Life Sciences

• Non-Steroidal Anti-Inflammatory Agents 100%
• Rheumatoid Arthritis 76%
• Economics 71%
• Quality of Life 59%
• Pharmaceutical Economics 40%
• Misoprostol 40%
• Anti-Inflammatory Agents 33%
• Costs and Cost Analysis 28%
• Pharmaceutical Preparations 25%
• Essential Drugs 21%
• Synthetic Prostaglandins 21%
• Gastrointestinal Agents 21%
• Musculoskeletal Pain 19%
• Drug Costs 18%
• Dyspepsia 17%
• Physiologic Monitoring 16%
• Ulcer 13%
• Arthritis 13%
• Patient Selection 13%
• Diarrhea 12%
• Hospitalization 11%
• Hemorrhage 9%
• Inflammation 9%
• Pain 8%
• Therapeutics 7%

Social Sciences

• quality of life 73%
• drug 52%
• costs 43%
• economics 39%
• literature 38%
• pain 29%
• essential drugs 24%
• monitoring 22%
• prophylaxis 20%
• event 17%
• hospitalization 17%
• surgery 15%
• drug use 13%
• medication 13%
• death 11%
• evidence 6%
• experience 4%